6 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... During Anticoagulation ... Structural - Pelvic masses ... #hematology #differential ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for appropriate dosing ... DVT = deep vein ... #Anticoagulation ... #Management #Hematology ... #Oncology
►
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
#Anticoagulation ... Extension #VTE #DVT ... #Hematology #Management ... #Diagnosis #Differential ... #Causes
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... bleeding risk during ... #Anticoagulation ... #Management #Hematology ... #Oncology
Summary of Oncologic Emergencies

Neutropenic fever:
- Fever + ANC < 500 → start cefepime ± vancomycin (if
Summary of Oncologic ... syndrome): - Hematologic ... Treat underlying cause ... stenting - Consider anticoagulation ... differentiating agent
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
) Classification ... express many of the genes ... Immunohistochemical studies (to differentiate ... lymphoma #diagnosis #classification ... #hematology #oncology